| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | WO2001008703A9 Recombinant rsv virus expression systems and vaccines |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
| 08/08/2002 | US20020107393 The crystalline monohydrate form provides increased stability over the anhydrous form. |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107272 Anti-HIV imidazolone derivatives |
| 08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107261 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107251 4-(hetero)aryl-3-oxo-3,4-dihydropyrido(2,3-b)pyrazine derivatives; prophylactic or therapeutic treatment of phosphodiesterase IV and tumor necrosis factor mediated diseases |
| 08/08/2002 | US20020107238 Topical antibiotic composition for treatment of eye infection |
| 08/08/2002 | US20020107224 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 08/08/2002 | US20020107221 Nucleosides with anti-hepatitis B virus activity |
| 08/08/2002 | US20020107220 By replication of the nucleic acids of the viruses in that distribution by use of a defective replication system; virus population lose pathogenic properties, infectiousness; treating viral diseases |
| 08/08/2002 | US20020107212 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 08/08/2002 | US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020107174 Microbial inhibitors or as synergistic enhancers of antibiotics and preservatives for cosmetics and other personal care preparations; endotoxin neutralizing proteins (ENPs) of horseshoe crabs |
| 08/08/2002 | US20020106776 pth |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106383 For immunizing animals |
| 08/08/2002 | US20020106376 Vaccines |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | DE10159291A1 Verfahren zur Herstellung eines partiellen oder vollständigen Wirkstoffüberzuges auf und in Implantaten und Onplantaten A process for preparing a partial or complete coating on active ingredient and in implants and Onplantaten |
| 08/08/2002 | DE10105039A1 Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/08/2002 | CA2766160A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436530A1 Environmentally regulated genes of streptococcus suis |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436427A1 Compositions and method of tissue superoxygenation |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | CA2432886A1 14-membered macrolides derived from leucomycins |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2429359A1 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | CA2426684A1 Inhibitors of prenyl-protein transferase |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229115A1 Novel c-type lectin and gene thereof |
| 08/07/2002 | EP1229042A1 Cyclic peptides and aids vaccines |
| 08/07/2002 | EP1229040A2 Nucleoside monophosphate derivative, a processor for their production and their use as immunosuppressive drugs |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229033A2 2-Fluoro-(oxid-thiopyran-4-yl)benzene derivatives |
| 08/07/2002 | EP1228784A2 Preparation for veterinary use |
| 08/07/2002 | EP1228769A1 Symbiotic regenerative composition |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228231A1 Mammalian-type glycosylation in plants |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228193A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 08/07/2002 | EP1228097A2 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228049A1 Antifungal sordaricin derivatives |
| 08/07/2002 | EP1228048A1 Sordaricin derivatives having antifungal activity |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228045A2 Heterocyclic cytotoxic agents |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227840A1 Adjuvanted genetic vaccines |
| 08/07/2002 | EP1227839A2 Live bacterial vaccines against escherichia coli o157:h7 |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227819A1 INHIBITING FtsZ PROTEIN (DE)POLYMERISATION |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227811A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |